Fondation Leenaards | Research funding on translational medical research


Event details

Date 07.03.2022  
Category Call for proposal

Every year, Fondation Leenaards allocates up to CHF 1.5 million to the Leenaards Prize for Translational Medical Research.

This research prize is awarded to 2-3 innovative projects, conducted by, at least, a university hospital (CHUV, HUG) and an academic partner (e.g. EPFL, UNIL, UNIGE) of the Lake Geneva region, investigating a clinical or health problem (including pathogenesis, diagnosis, prevention or therapy) from an original and innovative angle, and linking it to a component of advanced basic research, be it experimental research, bioinformatics or epidemiological analyses.

The project must:

  • include a human research component
  • stand on its own, but it can be embedded in the context of an existing project.

Who can apply:
  • At least one group at a university hospital (CHUV or HUG) AND one group at an academic institution (e.g. EPFL, UNIL, UNIGE) of the Lake Geneva Region; the third applicant can be based outside of this region. Preference is given to new collaborations.
  • The PI must be a clinical scientist (MD, MD-PhD, or PhD, below the age of 45).
  • Applicants should preferably be at a relatively early stage in their careers.
  • All applicants must hold a “stable position” for the entire duration of the project.
  • Applicants cannot have received this grant during the last 3 years (2019-2021). 

Funding and duration: CHF 500’000 - 750’000 for up to 36 months (not renewable).

  1. Deadline for Letter of Intent, a budget and a short CV: 7 March 2022.
  2. Pre-selection: 6 April 2022.
  3. Internal deadline for Institutional Support Letter: 16 May 2022 (contact [email protected])
  4. Deadline for Full Proposals: 1 June 2022.
  5. Final Decision: end of September 2022.
  6. Beginning of the Project: early January 2023.

For more information have a look at the call webpage, call document, the EPFL Toolkit, composition of the Jury and past granted projects.

Practical information

  • General public
  • Free


Event broadcasted in